Testing effectiveness (Phase 2)Looking for participantsNCT04267978
What this trial is testing
Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
Who this might be right for
Glioblastoma, RecurrentLower Grade Glioma, Recurrent
Beijing Sanbo Brain Hospital 109